Rybelsus

Active Ingredient(s): Semaglutide
FDA Approved: * September 20, 2019
Pharm Company: * NOVO NORDISK INC
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Rybelsus Overview

Semaglutide, sold under the brand name Ozempic among others, is an anti-diabetic medication used for the treatment of type 2 diabetes and chronic weight management.[11][12][13] Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen or as an oral form. One of its advantages over other antidia...

Read more Rybelsus Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Semaglutide

Recent Rybelsus Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Semaglutide
  • Solution: 0.25mg/0.5ml (0.25mg/0.5ml), 0.5mg/0.5ml (0.5mg/0.5ml), 1.7mg/0.75ml (1.7mg/0.75ml), 1mg/0.5ml (1mg/0.5ml), 2.4mg/0.75ml (2.4mg/0.75ml), 2mg/1.5ml (1.34mg/ml), 4mg/3ml (1.34mg/ml)
  • Tablet: 14mg, 3mg, 7mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rybelsus: (3 results)

Sorted by National Drug Code
  • 0169-4303 Rybelsus 3 mg Oral Tablet by Novo Nordisk
  • 0169-4307 Rybelsus 7 mg Oral Tablet by Novo Nordisk
  • 0169-4314 Rybelsus 14 mg Oral Tablet by Novo Nordisk

Other drugs which contain Semaglutide or a similar ingredient: (3 results)